Department of Obstetrics and Gynecology, Maternal-Fetal Unit, University of Health Sciences Umraniye Training and Research Hospital, Istanbul, Türkiye.
Department of Obstetrics and Gynecology, Health Sciences University Zeynep Kamil Women and Children's Diseases Training and Research Hospital, İstanbul, Türkiye.
Ginekol Pol. 2024;95(8):590-595. doi: 10.5603/GP.a2023.0005. Epub 2023 Mar 17.
The present study aimed to analyze of uterine smooth muscle tumors of uncertain malignant potential (STUMP) and the outcomes of patients with STUMP.
In this retrospective study, the data of patients diagnosed with STUMP in a single tertiary center between January 2005-January 2020 were reviewed. We assessed the demographic variables, treatment outcomes, time until recurrence, disease-free and overall survival of the patients.
Twenty-five patients diagnosed with STUMP were included in the study. The mean age of the patients was 43.2 ± 10.3 years. Thirteen of the 25 patients (52%) were treated by myomectomy, others received diagnoses following hysterectomy. The median follow-up time was 45.2 months. Recurrence was observed in three cases (12%), two of which were followed up without hysterectomy, and the third patient died by peritonitis carcinomatosa 60 months after diagnosis although she received cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) treatment.
This study evaluates the data of patients with STUMP. Our results reveal a STUMP recurrence of 12%, like those previously reported in the literature. Despite the possibility of malignant recurrence, fertility-preserving treatment with close follow-up should be tried, because of the relatively early age at diagnosis.
本研究旨在分析具有不确定恶性潜能的子宫平滑肌肿瘤(STUMP)及 STUMP 患者的结局。
在这项回顾性研究中,我们对 2005 年 1 月至 2020 年 1 月在一家三级中心诊断为 STUMP 的患者的数据进行了回顾。我们评估了患者的人口统计学变量、治疗结果、复发时间、无病生存率和总生存率。
本研究共纳入 25 例诊断为 STUMP 的患者。患者的平均年龄为 43.2±10.3 岁。25 例患者中有 13 例(52%)接受了子宫肌瘤切除术治疗,其他患者接受了子宫切除术诊断。中位随访时间为 45.2 个月。3 例(12%)患者出现复发,其中 2 例未行子宫切除术随访,第 3 例患者在诊断后 60 个月因腹膜癌死亡,尽管她接受了细胞减灭术和腹腔热灌注化疗(HIPEC)治疗。
本研究评估了 STUMP 患者的数据。我们的结果显示 STUMP 复发率为 12%,与文献报道的结果相似。尽管有恶性复发的可能,但应尝试保留生育能力的治疗,并密切随访,因为这些患者的诊断年龄相对较早。